Clinical Trials in Los Angeles

Showing 9381-9400 of 14,465 trials

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

NCT01969851

SP0966 is an exploratory study to investigate safety and efficacy of Lacosamide (LCM) in children with epilepsy syndromes associated with generalized seizures. LCM will be added to current antiepileptic treatment.

Epilepsy

UCB Pharma55 participantsStarted Feb 2014

Los Angeles, California, United States • Orlando, Florida, United States • Henderson, Nevada, United States +15 more locations

COMPLETEDPhase 1< 1 mile

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

NCT00858377

This first-in-human study of AMG 900 will be conducted in two parts: dose escalation and dose expansion. The dose escalation part of the study is aimed at evaluating the safety, tolerability and PK of oral AMG 900 in subjects with advanced solid tumors. Up to 50 subjects may be enrolled in dose escalation. The dose expansion part of the study will consist of 42 subjects in three taxane-resistant tumor types. The dose of AMG 900 will be dependent upon data from the dose escalation part of the study

Advanced MalignancyAdvanced Solid TumorsCancer+2 more

Amgen95 participantsStarted Aug 2009

Tucson, Arizona, United States • Los Angeles, California, United States • Baltimore, Maryland, United States +5 more locations

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Find Trials by Condition in Los Angeles

Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)

Benefits of Exercise Training in Women With Ischemic Syndrome

Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque

Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors

The vBlocT2D Study

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

MEmbranous Nephropathy Trial Of Rituximab

A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta